Clearstead Trust’s Halozyme HALO Stock Holding History

Clearstead Trust’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.09K	Hold	65	–	–	﹤0.01%	773
2026 Q1	$4.2K	Hold	65	–	–	﹤0.01%	788
2025 Q4	$4.38K	Hold	65	–	–	﹤0.01%	787
2025 Q3	$4.77K	Buy	+65	New	+$4.32K	﹤0.01%	779

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Clearstead Trust's HALO Position: Q2 2026 in Review

Clearstead Trust held its Halozyme (HALO) position steady in Q2 2026 at 65 shares worth $5.09K. The position accounts for ﹤0.01% of the portfolio, ranked #773.

Clearstead Trust first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Clearstead Trust held 65 shares of Halozyme worth $5.09K as of Q2 2026.
Clearstead Trust left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #773 holding.
Clearstead Trust first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.